首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Safety tolerability and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

【2h】

Safety tolerability and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

机译：自体大肠杆菌自身疫苗治疗室内尘螨哮喘的安全性耐受性及其对过敏性炎症的影响-一项前瞻性开放临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundAsthma is increasing worldwide and results from a complex immunological interaction between genetic susceptibility and environmental factors. Autovaccination with E. coli induces a strong TH-1 immune response, thus offering an option for the treatment of allergic diseases.

机译：背景技术哮喘在世界范围内正在增加，其原因是遗传易感性与环境因素之间复杂的免疫相互作用。大肠杆菌自身免疫可诱导强烈的TH-1免疫反应，从而为过敏性疾病的治疗提供了一种选择。

著录项

期刊名称 BMC Complementary and Alternative Medicine
作者
Markus A Rose; Bianca Weigand; Ralf Schubert; Johannes Schulze; Stefan Zielen;
展开▼
作者单位

展开▼
年(卷),期 2011(11),-1
年度 2011
页码 45
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
autovaccine safety tolerability house dust mite allergy asthma;

机译：自身疫苗;安全性;耐受性;屋尘螨过敏;哮喘;

相似文献

外文文献
中文文献
专利

1. Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial [J] . Markus A Rose, Bianca Weigand, Ralf Schubert, BMC Complementary and Alternative Medicine . 2011,第1期

机译：自体大肠杆菌自身疫苗治疗屋尘螨哮喘的安全性，耐受性及其对过敏性炎症的影响-前瞻性开放临床试验
2. Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial [J] . Takao Fujisawa, Terufumi Shimoda, Keisuke Masuyama, Allergology international: official journal of the Japanese Society of Allergology . 2018,第3期

机译：日本屋尘螨诱发的过敏性鼻炎和过敏性支气管哮喘患者使用TO-204皮下免疫疗法的长期安全性：多中心，开放标签临床试验
3. Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial [J] . Fujisawa Takao, Shimoda Terufumi, Masuyama Keisuke, Fortschritte der Physik . 2018,第3期

机译：皮下免疫疗法的长期安全性为204例日本患者粉尘螨诱导的过敏性鼻炎和过敏性支气管哮喘：多中心，开放标签临床试验
4. Sublingual immunotherapy in children with house dust mite induced allergic asthma [C] . Kumar Suman, Pey N., Sharma Nirankar, International Primary Care Respiratory Group . 2010

机译：含有房屋粉尘诱发过敏性哮喘的儿童的舌下免疫疗法
5. Efficacy, Tolerability and Safety of Operating Room Microlaryngoscopy Versus Office-Based Potassium Titanyl Phosphate (KTP) Laser Treatment of Benign Vocal Fold Lesions: A Longitudinal Prospective Evaluation of Multidimensional Voice Outcomes [D] . Chadwick, Keith Alan. 2020

机译：手术室微淋镜检查的功效，耐受性和安全性与良性声带病变的基于办事处的磷酸钾（KTP）激光治疗：多维语音结果的纵向前瞻性评估
6. A Real-Life One-Year Non-Interventional Study Assessing Safety Tolerability and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma [O] . Kirsten Sidenius, Peter Arvidsson, Roger Indbryn, 2021

机译：一种实际一年的非介入研究评估SQ HDM Slit-Tabl（Acarizax®）的安全性耐受性和治疗结果在House粉尘螨虫过敏性鼻炎中有或没有哮喘
7. Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial [O] . Rose Markus A., Weigand Bianca, Schubert Ralf, 2011

机译：自体大肠杆菌自身疫苗治疗室内尘螨哮喘的安全性，耐受性及其对过敏性炎症的影响-一项前瞻性开放临床试验

Safety tolerability and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅